OCT 15, 2021 9:32 AM PDT

Oxytocin Therapy Shows No Benefit for Autistic Children

WRITTEN BY: Annie Lennon

Intranasal oxytocin therapy works no better than a placebo against autism. The corresponding study was published in The New England Journal of Medicine.

Some experimental studies and small clinical trials have previously suggested that intranasal oxytocin therapy may reduce social and cognitive impairment among those with autism. Other research, however, has found the treatment to have no positive effect. 

Uncertainty about whether or not oxytocin therapy works led researchers to design a multi-site, placebo-controlled trial to see how it affects those with autism. 

For the trial, the researchers enrolled 290 children and adolescents aged between 3 and 17 years old. Patients were assigned on a 1:1 ratio according to age, and verbal fluency to either receive oxytocin or a placebo treatment via the nose. 

The researchers tracked each participant’s ability to socialize with the 13-item Aberrant Behavior checklist modified Social Withdrawal subscale given at the beginning, middle, and end of the study period. Participants were instructed to take either treatment daily for a period of 24 weeks. 

In the end, the researchers analyzed data from 139 participants who took oxytocin and 138 who were given a placebo. While the oxytocin treatment was well-tolerated with few side effects, the researchers ultimately found that it had no significant benefit compared to the placebo. 

“Thousands of children with autism spectrum disorder were prescribed intranasal oxytocin before it was adequately tested,” Jeremy Veenstra-VanderWeele, M.D., senior author of the research. “Thankfully, our data show that it is safe. Unfortunately, it is no better than placebo when used daily for months. These results indicate that clinicians and families should insist that there is strong evidence for the safety and benefit of new treatments before they are provided to patients in the clinic.”

The researchers conclude that, based on their results, it is not justifiable to conduct further investigation into oxytocin for autism spectrum disorders. 

 

Sources: The New England Journal of MedicineNeuroscience News

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
OCT 12, 2021
Immunology
Major Landmark in a 100-Year Search for a Malaria Vaccine
OCT 12, 2021
Major Landmark in a 100-Year Search for a Malaria Vaccine
In one of the greatest global health milestones of our time, the World Health Organization has approved the widespread d ...
OCT 12, 2021
Drug Discovery & Development
Preventing future pandemics - Scientists developing broadly protective vaccines against coronaviruses
OCT 12, 2021
Preventing future pandemics - Scientists developing broadly protective vaccines against coronaviruses
Researchers at Japan’s Osaka University recently developed and tested a novel vaccine that may protect a ...
OCT 25, 2021
Health & Medicine
Latest Cannabis Extraction Developments
OCT 25, 2021
Latest Cannabis Extraction Developments
In response to the growing demand for concentrates, cannabis product manufacturers are exploring new technological advan ...
NOV 08, 2021
Drug Discovery & Development
A case study of CBD's tumor shrinking potential
NOV 08, 2021
A case study of CBD's tumor shrinking potential
A recent article published in the British Medical Journal reported the case of a woman who shrank a tumor by taking CBD. ...
NOV 09, 2021
Microbiology
Can This Cat Parasite Become a Tumor Treatment?
NOV 09, 2021
Can This Cat Parasite Become a Tumor Treatment?
You may have heard of Toxoplasma gondii because it is so common. Cats carry this parasite, and anyone that cleans a litt ...
DEC 01, 2021
Drug Discovery & Development
Researchers develop a novel drug that can combat diabetic tissue damage
DEC 01, 2021
Researchers develop a novel drug that can combat diabetic tissue damage
Diabetes is a common disease that occurs when high levels of blood sugar start to silently damage bodily tissue and orga ...
Loading Comments...